Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

Share Price is delayed by 15 minutes
Get Live Data
0.475    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.05 (11.111%)
Market Cap: £4.43m
SUN Live PriceLast checked at - London Stock Exchange

Intraday Surgical Innovations Share Chart

US hospital group Agreement

18 Dec 2006 07:01

Surgical Innovations Group PLC18 December 2006 Press Release 18 December 2006 Surgical Innovations Group plc ("Surgical" or "the Group") Provider of Choice for major US hospital group Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer ofinnovative surgical devices, today announces that it has been approved by theNorth Shore Long Island Jewish Health System ("North Shore") as an accreditedsupplier of laparoscopic equipment. Following extensive trials across all disciplines of laparoscopic surgery withinthe North Shore hospital group, the Group's market-leading 'resposable' (amixture of both reusable and disposable items) and versatile YelloPort abdominalaccess system will be supplied to operating theatres in pre-prepared equipmenttrays, tailored to each type of operation. North Shore is the USA's third-largest non-profit secular healthcare systemsgroup, comprising 15 hospitals, with in excess of 6,000 beds. With a US$4billion annual operating budget and more than 38,000 employees, North Shoreservices an area of 5.2 million people in New York State. North Shore treats more than 235,000 in-patients annually and offers a fullspectrum of advanced minimally invasive procedures. There are 4.4 millionlaparoscopic surgical procedures carried out each year in the US (Source:Patient Safety and Quality Healthcare journal, May/June 2005) and the worldwidedemand for such operations is escalating with the majority of countries nowundertaking these procedures on a routine basis. Graham Bowland, Joint Managing Director of Surgical Innovations, commented: "Weare delighted to have been accredited by North Shore and look forward to furtheropportunities to demonstrate our range of surgical instruments. We believe thisis a positive step in the growth of the Group and are confident that thisinvaluable endorsement from pre-eminent surgeons at a respected hospital groupwill help us gain accredited supplier status in further hospitals across theUSA." - Ends - For further information: Surgical Innovations Group plc Graham Bowland, Managing Director Tel: +44 (0) 113 230 7597 graham.bowland@surginno.co.uk www.sigroupplc.com Hanson Westhouse LLP Tim Feather Tel: +44 (0) 113 246 2610 tim.feather@hansonwesthouse.com www.hansonwesthouse.com Media enquiries: Abchurch Gareth Mead / Justin Heath Tel: +44 (0) 20 7398 7710 gareth.mead@abchurch-group.com www.abchurch-group.com Notes to Editors: Surgical Innovations Group plc specialises in the design and manufacture ofinnovative devices for use in minimally invasive surgery and industrial markets. The Group employs over 50 people and is headquartered in Leeds. The Group's medical division is focused on strong international growth in twospecialist areas namely minimally invasive surgery, where products are used in'keyhole' surgery which is more accurately known as laparoscopic surgery, andproducts for autologous blood transfusion whereby a patient's own blood isrecycled. The Group's industrial division utilises Surgical Innovations' core medicaldevice design expertise and technology in innovative engineering applications. For more information, see www.sigroupplc.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Jun 20267:00 amRNSDirector appointment
5th Jun 20267:00 amRNSNotice of AGM & Posting of Annual Report &Accounts
21st Apr 20267:00 amRNSFinal Results
9th Apr 20267:00 amRNSNotice of Results and Investor Presentation
8th Jan 20267:00 amRNSChief Financial Officer update
18th Dec 20257:00 amRNSTrading Update
28th Nov 20257:00 amRNSNew LTIP & Grant of Options
29th Sep 20257:05 amRNSBoard Changes
29th Sep 20257:00 amRNSHalf-year Report
17th Sep 20253:15 pmRNSNotice of Results
27th Jun 20254:42 pmRNSResult of AGM
26th Jun 202511:36 amRNSWithdrawal of AGM Resolutions 9 and 10
4th Jun 20258:00 amRNSNotice of AGM & Posting of Annual Report &Accounts
30th May 20257:00 amRNSFinal Results
10th Apr 20257:00 amRNSTrading update
1st Apr 202511:30 amRNSUpdate on timing of 2024 Full Year results
19th Feb 202510:11 amRNSHolding(s) in Company
17th Feb 20254:12 pmRNSHolding(s) in Company
12th Feb 20257:00 amRNSFY24 Trading Update & & Directorship Change
30th Sep 20247:00 amRNSHalf-year Report
10th Sep 20247:00 amRNSNotice of Results
27th Aug 20243:51 pmRNSHolding(s) in Company
27th Aug 20243:49 pmRNSHolding(s) in Company
19th Aug 20241:06 pmRNSHolding(s) in Company
19th Aug 20241:01 pmRNSHolding(s) in Company
29th Jul 202412:18 pmRNSHolding(s) in Company
25th Jul 20244:04 pmRNSHolding(s) in Company
17th Jun 20244:43 pmRNSResult of AGM
10th Jun 20247:00 amRNSDirectorate Change - Appointment of CFO
23rd May 20247:00 amRNSNotice of AGM and Posting of Annual Report
22nd Apr 20243:34 pmRNSHolding(s) in Company
19th Apr 20246:25 pmRNSHolding(s) in Company
18th Apr 20247:01 amRNSFinal Results
18th Apr 20247:00 amRNSNew exclusive UK distribution agreements secured
9th Apr 20247:00 amRNSDirectorate Change & Notice of Results
29th Jan 20247:00 amRNSYear-end 2023 Trading Update
19th Dec 20237:00 amRNSDirectorate Change
5th Dec 20237:00 amRNSDirectorate Change
19th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSTrading Update and Notice of Results
27th Jun 202312:12 pmRNSResult of AGM
27th Jun 20237:00 amRNSAGM Statement
26th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
25th May 202311:11 amRNSDirector/PDMR Shareholding - Replacement
25th May 20237:00 amRNSDirector/PDMR Shareholding
22nd May 20237:00 amRNSDirectorate changes and board succession planning
29th Mar 20237:00 amRNSFinal Results
3rd Mar 20237:00 amRNSNotice of Results and Investor Presentation
23rd Jan 20237:00 amRNSYear-end Trading Update
21st Sep 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.